Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 125 of 196 entries
View as:

BNT162b2 Vaccination With 2 Doses in COVID-19 Negative Volunteers and With a Single Dose in COVID-19 Positive Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT04824638 Org: User:
Start: 03/08/21 End: 12/02/23 Due: 12/02/24

Early Treatment of Vulnerable Individuals With Non-Severe SARS-CoV-2 Infection

Phase: N/A Priority: Normal
NCT ID: NCT04920838 Org: User:
Start: 04/12/21 End: 08/31/23 Due: 08/31/24

IL-23/IL-12 Imbalance and T Lymphocyte Polarization in HIV Infection

Phase: N/A Priority: Normal
NCT ID: NCT01942655 Org: User:
Start: 06/01/14 End: 03/01/18 Due: 03/01/19

Prevention of COVID-19 Complications in High-risk Subjects Infected by SARS-CoV-2 and Eligible for Treatment Under a Cohort ATU ('Autorisation Temporaire d'Utilisation') OR or Authorisation for Early Access (AAP). A Prospectvie Cohort.

Phase: N/A Priority: Normal
NCT ID: NCT04885452 Org: User:
Start: 09/21/21 End: 12/18/23 Due: 12/18/24

Efficacy and Safety of 2 Raltegravir Doses in Naive HIV-1-infected Patients Receiving Rifampin for Active Tuberculosis

Phase: N/A Priority: Normal
NCT ID: NCT00822315 Org: User:
Start: 07/31/09 End: 05/31/12 Due: 05/31/13

Study Comparing the Tolerability and Viral Reduction of the Combination of IFN a-2b XL + Ribavirin Versus Peg IFN a-2b + Ribavirin in Patients With Chronic Hepatitis C, Genotype 1 or 4

Phase: N/A Priority: Normal
NCT ID: NCT01010646 Org: User:
Start: 03/31/10 End: 11/30/13 Due: 11/30/14

French Cohort of Therapeutic Failure and Resistances in Patients Treated With a Protease Inhibitor (Telaprevir or Boceprevir), Pegylated Interferon and Ribavirin

Phase: N/A Priority: Normal
NCT ID: NCT01514890 Org: User:
Start: 02/28/11 End: 03/31/14 Due: 03/31/15

Life Course, HIV and Hepatitis B Among African Migrants Living in Ile-de-France

Phase: N/A Priority: Normal
NCT ID: NCT02566148 Org: User:
Start: 02/29/12 End: 05/31/13 Due: 05/31/14

Early and Intermittent Antiretroviral Therapy in Naive HIV Infected Adults

Phase: N/A Priority: Normal
NCT ID: NCT00820118 Org: User:
Start: 05/31/09 End: 05/31/12 Due: 05/31/13

Pilot Study to Assess Efficacy and Safety of a Triple Therapy With Asunaprevir, Daclatasvir, and BMS-791325 in HCV Genotype 4-infected Patients After Failure of Pegylated Interferon-Ribavirin Regimen

Phase: N/A Priority: Normal
NCT ID: NCT02309450 Org: User:
Start: 12/31/14 End: 08/31/16 Due: 08/31/17

Assessment of HIV Remission Upon cART Interruption in Early Treated Individuals Carrying the MHC B35/53Bw4TTC2 Genotype

Phase: N/A Priority: Normal
NCT ID: NCT05482854 Org: User:
Start: 03/20/23 End: 07/31/25 Due: 07/31/26

Cohort Study of Volunteers That Have Participated to Preventive HIV-1 Vaccine Trials

Phase: N/A Priority: Normal
NCT ID: NCT00789789 Org: User:
Start: 12/31/08 End: 09/30/16 Due: 09/30/17

Observational Study of B-Cell Non Hodgkin Lymphomas (NHL) Associated With Hepatitis C Virus (HCV)

Phase: N/A Priority: Normal
NCT ID: NCT01545544 Org: User:
Start: 11/30/06 End: 11/30/14 Due: 11/30/15

Prophylaxis Vaccine Antibodies Ebola

Phase: N/A Priority: Normal
NCT ID: NCT04822376 Org: User:
Start: 10/17/21 End: 04/30/22 Due: 04/30/23

Assisted Notification of Partners of Men Having Sex With Men Discovering Their Seropositivity

Phase: N/A Priority: Normal
NCT ID: NCT06419491 Org: User:
Start: 06/01/24 End: 05/31/26 Due: 05/31/27

Epidemiological Investigation of COVID-19 in Laos Using a One-Health Approach in Human and Animals

Phase: N/A Priority: Normal
NCT ID: NCT04716543 Org: User:
Start: 08/01/21 End: 03/31/22 Due: 03/31/23

National Cohort of Patients Co-infected With Hepatitis B and Delta Viruses

Phase: N/A Priority: Normal
NCT ID: NCT04166266 Org: User:
Start: 02/19/20 End: 06/30/28 Due: 06/30/29

Evaluation of an Innovative Tuberculosis Diagnostic Test

Phase: N/A Priority: Normal
NCT ID: NCT02573623 Org: User:
Start: 07/31/13 End: 12/31/15 Due: 12/31/16

Early Lung Cancer Diagnosis in HIV Infected Population With an Important Smoking History With Low Dose CT: a Pilot Study

Phase: N/A Priority: Normal
NCT ID: NCT01207986 Org: User:
Start: 02/28/11 End: 08/31/14 Due: 08/31/15

Community Intervention to Eliminate HCV Among People Who Use Drugs.

Phase: N/A Priority: Normal
NCT ID: NCT05794646 Org: User:
Start: 10/02/23 End: 06/15/25 Due: 06/15/26

A Study to Determine the Cartography of Virologic Reservoir Related to Antiretroviral Concentrations in HIV-1 Chronic Patients Treated by a First Line Treatment Containing bictégravir, Emtricitabine and ténofovir alafénamide

Phase: N/A Priority: Normal
NCT ID: NCT05222945 Org: User:
Start: 04/01/25 End: 10/31/25 Due: 10/31/26

Evaluation of the National Treatment Program of Hepatitis C in Egypt

Phase: N/A Priority: Normal
NCT ID: NCT02101177 Org: User:
Start: 04/30/14 End: 12/31/15 Due: 12/31/16

Outcome at 5 Years of Early Treated HIV Infected Infants in the PEDIACAM Project

Phase: N/A Priority: Normal
NCT ID: NCT02043418 Org: User:
Start: 11/30/07 End: 07/31/25 Due: 07/31/26

Assessment of the Efficacy and Safety of Tecovirimat in Patients With Monkeypox Virus Disease

Phase: N/A Priority: Normal
NCT ID: NCT05597735 Org: User:
Start: 03/03/23 End: 11/30/26 Due: 11/30/27

HIV Diagnosis and Treatment at Birth for Newborn With High Risk HIV Exposure

Phase: N/A Priority: Normal
NCT ID: NCT03642704 Org: User:
Start: 02/22/17 End: 09/17/19 Due: 09/17/20